A Meta-Analysis Studying the Difference in Response to Trastuzumab-Deruxtecan Based on HER2 Immunohistochemistry Staining in HER2 Low Metastatic Breast Cancer Patients

Authors

Prashanth Ashok Kumar, Division of Hematology-Oncology, Upstate Cancer Center, Upstate University Hospital, Syracuse, NY.
Michael Sandhu, Department of Medicine, Upstate University Hospital, Syracuse, NY.
Devashish Desai, Department of Medicine, Upstate University Hospital, Syracuse, NY.
Metlapalli Sravanthi Venkata, Division of Hematology-Oncology, Upstate Cancer Center, Upstate University Hospital, Syracuse, NY.
Vishnu Suresh Kumar, Division of Gastroenterology, Upstate University Hospital, Syracuse, NY.
Sam Benjamin, Division of Hematology-Oncology, Upstate Cancer Center, Upstate University Hospital, Syracuse, NY.

Document Type

Journal Article

Publication Date

4-29-2025

Journal

American journal of therapeutics

DOI

10.1097/MJT.0000000000001894

APA Citation

Ashok Kumar, Prashanth; Sandhu, Michael; Desai, Devashish; Sravanthi Venkata, Metlapalli; Kumar, Vishnu Suresh; and Benjamin, Sam, "A Meta-Analysis Studying the Difference in Response to Trastuzumab-Deruxtecan Based on HER2 Immunohistochemistry Staining in HER2 Low Metastatic Breast Cancer Patients" (2025). GW Authored Works. Paper 6969.
https://hsrc.himmelfarb.gwu.edu/gwhpubs/6969

Department

Medicine